Compare ATAI & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATAI | LPAA |
|---|---|---|
| Founded | 2018 | 2024 |
| Country | United States | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 310.2M |
| IPO Year | 2025 | N/A |
| Metric | ATAI | LPAA |
|---|---|---|
| Price | $4.00 | $10.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $15.88 | N/A |
| AVG Volume (30 Days) | ★ 7.0M | 20.0K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,089,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $31.91 |
| Revenue Growth | ★ 1227.60 | N/A |
| 52 Week Low | $1.66 | $10.33 |
| 52 Week High | $6.73 | $10.79 |
| Indicator | ATAI | LPAA |
|---|---|---|
| Relative Strength Index (RSI) | 46.55 | 53.10 |
| Support Level | $3.89 | $10.40 |
| Resistance Level | $4.13 | $10.79 |
| Average True Range (ATR) | 0.22 | 0.02 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 15.00 | 33.33 |
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Launch One Acquisition Corp is a blank check company.